2024 Q2 Form 10-Q Financial Statement

#000143774924014986 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $54.59M $65.57M
YoY Change -10.52% -14.02%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $11.80M $12.06M
YoY Change -13.04% -7.29%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.324M $4.654M
YoY Change -12.34% 13.98%
% of Gross Profit
Operating Expenses $15.13M $16.71M
YoY Change -12.89% -2.21%
Operating Profit $50.41M $59.70M
YoY Change -31.71% -27.31%
Interest Expense -$4.349M $3.487M
YoY Change -224.54% 22.22%
% of Operating Profit -8.63% 5.84%
Other Income/Expense, Net
YoY Change
Pretax Income $46.06M $56.21M
YoY Change -34.51% -29.09%
Income Tax
% Of Pretax Income
Net Earnings $46.06M $56.21M
YoY Change -34.51% -29.09%
Net Earnings / Revenue 84.38% 85.72%
Basic Earnings Per Share
Diluted Earnings Per Share $2.29 $3.68
COMMON SHARES
Basic Shares Outstanding 12.96M 12.96M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.34M $10.99M
YoY Change 201.4% -37.75%
Cash & Equivalents $32.34M $10.99M
Short-Term Investments
Other Short-Term Assets $3.114M $3.494M
YoY Change 8.69% 8.64%
Inventory
Prepaid Expenses
Receivables $30.62M $33.87M
Other Receivables $0.00 $0.00
Total Short-Term Assets $66.08M $48.36M
YoY Change 30.29% -15.73%
LONG-TERM ASSETS
Property, Plant & Equipment $411.1M $414.2M
YoY Change -4.13% -4.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $265.9M $268.6M
YoY Change -8.58% -9.05%
Other Assets $8.412M $8.034M
YoY Change 7.79% 5.41%
Total Long-Term Assets $723.5M $729.8M
YoY Change -5.99% -6.23%
TOTAL ASSETS
Total Short-Term Assets $66.08M $48.36M
Total Long-Term Assets $723.5M $729.8M
Total Assets $789.6M $778.2M
YoY Change -3.74% -6.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $933.0K $1.514M
YoY Change -38.78% 4.27%
Accrued Expenses $7.225M $5.064M
YoY Change 26.42% 46.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $14.21M $14.20M
YoY Change -61.32% -63.64%
Total Short-Term Liabilities $27.14M $27.41M
YoY Change -47.23% -47.96%
LONG-TERM LIABILITIES
Long-Term Debt $196.1M $174.6M
YoY Change 34.61% 30.47%
Other Long-Term Liabilities $6.619M $6.305M
YoY Change 2.43% 2.96%
Total Long-Term Liabilities $202.7M $180.9M
YoY Change 33.24% 29.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.14M $27.41M
Total Long-Term Liabilities $202.7M $180.9M
Total Liabilities $270.3M $246.7M
YoY Change 12.44% 6.57%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $519.3M $531.5M
YoY Change
Total Liabilities & Shareholders Equity $789.6M $778.2M
YoY Change -3.74% -6.88%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $46.06M $56.21M
YoY Change -34.51% -29.09%
Depreciation, Depletion And Amortization $3.324M $4.654M
YoY Change -12.34% 13.98%
Cash From Operating Activities $56.63M $71.50M
YoY Change -30.39% -1.92%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $5.302M $812.0K
YoY Change 762.11% 16.17%
Cash From Investing Activities $5.302M $812.0K
YoY Change 773.48% 16.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $55.70M
YoY Change -37.91%
Cash From Financing Activities -40.58M -$73.31M
YoY Change -54.34% -22.86%
NET CHANGE
Cash From Operating Activities 56.63M $71.50M
Cash From Investing Activities 5.302M $812.0K
Cash From Financing Activities -40.58M -$73.31M
Net Change In Cash 21.35M -$999.0K
YoY Change -408.3% -95.34%
FREE CASH FLOW
Cash From Operating Activities $56.63M $71.50M
Capital Expenditures $0.00 $0.00
Free Cash Flow $56.63M $71.50M
YoY Change -30.38% -1.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
12960064
CY2023Q4 us-gaap Limited Partners Capital Account Units Issued
LimitedPartnersCapitalAccountUnitsIssued
12634642
CY2023Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
12634642
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2023Q4 nrp Discount Rate
DiscountRate
0.15 pure
CY2024Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
0 usd
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
0 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
71666
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
71666
CY2024Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
71666
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
71666
CY2024Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
1000
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
1000
CY2024Q1 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
1850
CY2023Q4 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
1850
CY2024Q1 us-gaap Limited Partners Capital Account Units Issued
LimitedPartnersCapitalAccountUnitsIssued
12960064
CY2024Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-31465
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2164875
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1415 Louisiana Street, Suite 3325
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77002
CY2024Q1 dei City Area Code
CityAreaCode
713
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
751-7507
CY2024Q1 dei Security12b Title
Security12bTitle
Common Units representing limited partner interests
CY2024Q1 dei Trading Symbol
TradingSymbol
NRP
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10990000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11989000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33874000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41086000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3494000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2218000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
48358000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
55293000 usd
CY2024Q1 us-gaap Land
Land
24008000 usd
CY2023Q4 us-gaap Land
Land
24008000 usd
CY2024Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
390176000 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
394483000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13340000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13682000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
268634000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
276549000 usd
CY2024Q1 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
25632000 usd
CY2023Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
26321000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8034000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7540000 usd
CY2024Q1 us-gaap Assets
Assets
778182000 usd
CY2023Q4 us-gaap Assets
Assets
797876000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1514000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
885000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5064000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12987000 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
995000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
584000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5635000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4599000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
14202000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
30785000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
27410000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49840000 usd
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
38348000 usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
38356000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
174595000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
124273000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6305000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7172000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
246658000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
219641000 usd
CY2024Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
47181000 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
47181000 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12960064
CY2024Q1 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
474095000 usd
CY2023Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
503076000 usd
CY2024Q1 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
7721000 usd
CY2023Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
8005000 usd
CY2024Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
4804000 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
23095000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2277000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3122000 usd
CY2024Q1 us-gaap Partners Capital
PartnersCapital
484343000 usd
CY2023Q4 us-gaap Partners Capital
PartnersCapital
531054000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
778182000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
797876000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5450000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
19254000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
165000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
96000 usd
CY2024Q1 nrp Revenue Net Including Gain Loss On Disposition Of Assets
RevenueNetIncludingGainLossOnDispositionOfAssets
76414000 usd
CY2023Q1 nrp Revenue Net Including Gain Loss On Disposition Of Assets
RevenueNetIncludingGainLossOnDispositionOfAssets
99219000 usd
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
5733000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
7163000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4654000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4083000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6327000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5845000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
16714000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
17091000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
59700000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
82128000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
3487000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2853000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
56213000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
79275000 usd
CY2024Q1 nrp Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Allocated To Preferred Unit Holders
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestAllocatedToPreferredUnitHolders
-2150000 usd
CY2023Q1 nrp Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Allocated To Preferred Unit Holders
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestAllocatedToPreferredUnitHolders
-6661000 usd
CY2024Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
-0 usd
CY2023Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
16228000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
54063000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
56386000 usd
CY2024Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
52982000 usd
CY2023Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
55258000 usd
CY2024Q1 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
-1081000 usd
CY2023Q1 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
-1128000 usd
CY2024Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
4.13
CY2023Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
4.4
CY2024Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
3.83
CY2023Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
3.44
CY2024Q1 us-gaap Profit Loss
ProfitLoss
56213000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
79275000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
845000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19583000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
57058000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
59692000 usd
CY2023Q4 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
531054000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
56213000 usd
CY2024Q1 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
42186000 usd
CY2024Q1 nrp Decrease For Distributions To Unitholders
DecreaseForDistributionsToUnitholders
2150000 usd
CY2024Q1 nrp Partners Capital Account Unitbased Compensation Amortization
PartnersCapitalAccountUnitbasedCompensationAmortization
-3971000 usd
CY2024Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
227000 usd
CY2024Q1 nrp Partners Capital Account Warrant Settlement
PartnersCapitalAccountWarrantSettlement
55689000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
845000 usd
CY2024Q1 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
484343000 usd
CY2022Q4 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
477457000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
79275000 usd
CY2023Q1 us-gaap Partners Capital Account Redemptions
PartnersCapitalAccountRedemptions
-16228000 usd
CY2023Q1 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
40900000 usd
CY2023Q1 nrp Decrease For Distributions To Unitholders
DecreaseForDistributionsToUnitholders
8086000 usd
CY2023Q1 nrp Partners Capital Account Unitbased Compensation Amortization
PartnersCapitalAccountUnitbasedCompensationAmortization
-1178000 usd
CY2023Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
142000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19583000 usd
CY2023Q1 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
470899000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
56213000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
79275000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4654000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4083000 usd
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
14210000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
10780000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5450000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
19254000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
165000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
96000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-813000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-610000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2964000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2491000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-749000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
25000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9433000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7061000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
629000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-541000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8225000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8805000 usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
412000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
263000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1028000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-154000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2642000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1618000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
71499000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
72900000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
165000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
101000 usd
CY2024Q1 us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
647000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
598000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
812000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
697000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
89357000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
94200000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
55696000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
89696000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
-0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
47499000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
55689000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
-0 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-6946000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3052000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-73310000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-95033000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-999000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21436000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11989000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
39091000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10990000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17655000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
2843000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
2474000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2024Q1 nrp Number Of Wholly Owned Operating Companies
NumberOfWhollyOwnedOperatingCompanies
1 pure
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65574000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76271000 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
42955000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
46437000 usd
CY2024Q1 nrp Deferred Revenue Contractual Minimum Payments
DeferredRevenueContractualMinimumPayments
6979000 usd
CY2023Q1 nrp Deferred Revenue Contractual Minimum Payments
DeferredRevenueContractualMinimumPayments
7770000 usd
CY2024Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
5951000 usd
CY2023Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
7924000 usd
CY2024Q1 us-gaap Deferred Revenue
DeferredRevenue
43983000 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
46283000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y4M24D
CY2024Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
60378000 usd
CY2023Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
16200000 usd
CY2023Q1 nrp Preferred Units Number Of Redeemed Units
PreferredUnitsNumberOfRedeemedUnits
47499
CY2024Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
52982000 usd
CY2023Q1 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
55258000 usd
CY2024Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
12832000
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
12570000
CY2024Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
4.13
CY2023Q1 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
4.4
CY2024Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
12832000
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
12570000
CY2024Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Preferred Units
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfPreferredUnits
775000
CY2023Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Preferred Units
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfPreferredUnits
3778000
CY2024Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Warrants
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfWarrants
521000
CY2023Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Warrants
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfWarrants
1255000
CY2024Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Unit Awards
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfUnitAwards
265000
CY2023Q1 nrp Weighted Average Number Diluted Limited Partnership Units Outstanding Adjustment Effect Of Unit Awards
WeightedAverageNumberDilutedLimitedPartnershipUnitsOutstandingAdjustmentEffectOfUnitAwards
209000
CY2024Q1 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
14393000
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
17812000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
56213000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
79275000 usd
CY2024Q1 nrp Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Allocated To Preferred Unit Holders Including Dilutive Impact
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestAllocatedToPreferredUnitHoldersIncludingDilutiveImpact
-0 usd
CY2023Q1 nrp Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Allocated To Preferred Unit Holders Including Dilutive Impact
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestAllocatedToPreferredUnitHoldersIncludingDilutiveImpact
586000 usd
CY2024Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
-0 usd
CY2023Q1 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
16228000 usd
CY2024Q1 nrp Net Income Loss Allocated To General Partners And Limited Partners Diluted
NetIncomeLossAllocatedToGeneralPartnersAndLimitedPartnersDiluted
56213000 usd
CY2023Q1 nrp Net Income Loss Allocated To General Partners And Limited Partners Diluted
NetIncomeLossAllocatedToGeneralPartnersAndLimitedPartnersDiluted
62461000 usd
CY2024Q1 nrp Income Loss Attributable To Parent And Other Income From Warrant Liability Fair Value Adjustments Allocated To General Partner
IncomeLossAttributableToParentAndOtherIncomeFromWarrantLiabilityFairValueAdjustmentsAllocatedToGeneralPartner
-1124000 usd
CY2023Q1 nrp Income Loss Attributable To Parent And Other Income From Warrant Liability Fair Value Adjustments Allocated To General Partner
IncomeLossAttributableToParentAndOtherIncomeFromWarrantLiabilityFairValueAdjustmentsAllocatedToGeneralPartner
-1249000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
55089000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
61212000 usd
CY2024Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
3.83
CY2023Q1 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
3.44
CY2024Q1 nrp Revenues Excluding Gain On Sale Of Asset
RevenuesExcludingGainOnSaleOfAsset
76249000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
165000 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5733000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4654000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6327000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
3487000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
56213000 usd
CY2023Q1 nrp Revenues Excluding Gain On Sale Of Asset
RevenuesExcludingGainOnSaleOfAsset
99123000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
96000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7163000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4083000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5845000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
2853000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
79275000 usd
CY2024Q1 us-gaap Mineral Properties Gross
MineralPropertiesGross
695408000 usd
CY2024Q1 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
305232000 usd
CY2024Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
390176000 usd
CY2023Q4 us-gaap Mineral Properties Gross
MineralPropertiesGross
695408000 usd
CY2023Q4 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
300925000 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
394483000 usd
CY2024Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
189185000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
155525000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
388000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
467000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
188797000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
155058000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
14202000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
30785000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
174595000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
124273000 usd
CY2024Q1 nrp Discount Rate
DiscountRate
0.15 pure
CY2024Q1 nrp Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue
6700000 usd
CY2023Q1 nrp Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Grants In Period Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodFairValue
15900000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
17500000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
13300000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
483000
CY2023Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
46.21
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
65000
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
103.5
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
197000
CY2024Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
38.76
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
351000
CY2024Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
60.91
CY2024Q1 nrp Shortterm Receivables Gross
ShorttermReceivablesGross
40992000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4896000 usd
CY2024Q1 nrp Shortterm Receivables Net Of Cecl Allowance
ShorttermReceivablesNetOfCeclAllowance
36096000 usd
CY2023Q4 nrp Shortterm Receivables Gross
ShorttermReceivablesGross
47170000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5655000 usd
CY2023Q4 nrp Shortterm Receivables Net Of Cecl Allowance
ShorttermReceivablesNetOfCeclAllowance
41515000 usd
CY2024Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
26552000 usd
CY2024Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
920000 usd
CY2024Q1 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
25632000 usd
CY2023Q4 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
27265000 usd
CY2023Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
944000 usd
CY2023Q4 us-gaap Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
26321000 usd
CY2024Q1 nrp Total Receivables Gross
TotalReceivablesGross
67544000 usd
CY2024Q1 nrp Cecl Allowance Total
CECLAllowanceTotal
5816000 usd
CY2024Q1 nrp Total Receivables Net Of Cecl Allowance
TotalReceivablesNetOfCeclAllowance
61728000 usd
CY2023Q4 nrp Total Receivables Gross
TotalReceivablesGross
74435000 usd
CY2023Q4 nrp Cecl Allowance Total
CECLAllowanceTotal
6599000 usd
CY2023Q4 nrp Total Receivables Net Of Cecl Allowance
TotalReceivablesNetOfCeclAllowance
67836000 usd
CY2024Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-800000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-600000 usd

Files In Submission

Name View Source Status
0001437749-24-014986-index-headers.html Edgar Link pending
0001437749-24-014986-index.html Edgar Link pending
0001437749-24-014986.txt Edgar Link pending
0001437749-24-014986-xbrl.zip Edgar Link pending
ex_616241.htm Edgar Link pending
ex_616242.htm Edgar Link pending
ex_616243.htm Edgar Link pending
ex_616244.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nrp-20240331.xsd Edgar Link pending
nrp20220630_10qimg001.jpg Edgar Link pending
nrp20240331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nrp-20240331_cal.xml Edgar Link unprocessable
nrp-20240331_def.xml Edgar Link unprocessable
nrp-20240331_lab.xml Edgar Link unprocessable
nrp-20240331_pre.xml Edgar Link unprocessable
nrp20240331_10q_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending